Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Rezatapopt

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PMV Pharma Updates Rezatapopt Data In PYNNACLE Ph2 Trial
    PMV Pharma Updates Rezatapopt Data In PYNNACLE Ph2 Trial

    24 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/24/3172959/0/en/PMV-Pharmaceuticals-Announces-Updated-Rezatapopt-Monotherapy-Interim-Data-From-Ongoing-PYNNACLE-Phase-2-Trial-Across-Multiple-Solid-Tumors-With-a-TP53-Y220C-Mutation.html

    GLOBENEWSWIRE
    24 Oct 2025
    Share Share
    PMV Pharma To Present Rezatapopt Ph 2 Data at AACR-NCI-EORTC
    PMV Pharma To Present Rezatapopt Ph 2 Data at AACR-NCI-EORTC

    13 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/13/3165785/0/en/PMV-Pharmaceuticals-to-Present-Rezatapopt-Pivotal-Phase-2-Initial-Analysis-and-Natural-History-Study-Results-at-the-2025-AACR-NCI-EORTC-International-Conference-on-Molecular-Target.html

    GLOBENEWSWIRE
    13 Oct 2025
    Share Share
    PMV Reveals Positive Rezatapopt Data From Ph 2 TP53 Y220C Trial
    PMV Reveals Positive Rezatapopt Data From Ph 2 TP53 Y220C Trial

    10 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/10/3147627/0/en/PMV-Pharmaceuticals-Announces-Promising-Rezatapopt-Monotherapy-Interim-Data-From-PYNNACLE-Phase-2-Trial-Across-Multiple-Solid-Tumors-With-a-TP53-Y220C-Mutation.html

    GLOBENEWSWIRE
    10 Sep 2025
    Share Share
    PMV Pharma Reports Q2 2024 Results And PYNNACLE Trial Update
    PMV Pharma Reports Q2 2024 Results And PYNNACLE Trial Update

    08 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/08/2926889/0/en/PMV-Pharmaceuticals-Reports-Second-Quarter-2024-Financial-Results-and-Provides-a-Progress-Update-on-PYNNACLE-Clinical-Trial.html

    GLOBENEWSWIRE
    08 Aug 2024
    Share Share
    Foundation Medicine, PMV Pharma Develop CDx For p53 Reactivator
    Foundation Medicine, PMV Pharma Develop CDx For p53 Reactivator

    29 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/29/2889690/0/en/Foundation-Medicine-and-PMV-Pharma-Announce-Collaboration-to-Develop-Companion-Diagnostic-for-Rezatapopt-a-First-In-Class-Investigational-Selective-p53-Y220C-Reactivator.html

    GLOBENEWSWIRE
    29 May 2024
    Share Share
    Foundation Medicine, PMV Pharma CDx Tie-Up For p53 Reactivator
    Foundation Medicine, PMV Pharma CDx Tie-Up For p53 Reactivator

    29 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240529460179/en

    BUSINESSWIRE
    29 May 2024
    Share Share